Nephros Inc (NEPH) Stock Analysis

Nephros Inc (NEPH) is a publicly traded company in the HEALTHCARE sector. It trades at $3.80, carries a market capitalization of $39.73M, a price-to-earnings ratio of 52.29. This page summarizes the public market data, fundamentals, and frequently asked questions for NEPH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Nephros Inc currently has a Bullish sentiment score of 0.26.

About Nephros Inc

Nephros, Inc. is a commercial-stage medical technology company headquartered in South Orange, New Jersey, dedicated to providing advanced water purification solutions tailored for the healthcare and commercial sectors. The company's innovative filtration technologies enhance water quality and safety in clinical environments, crucial for improving patient outcomes and operational efficiencies. By meeting rigorous regulatory standards, Nephros is strategically positioned in the expanding market...

GNG Research Analysis

GNG Research scores Nephros Inc (NEPH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NEPH.

Frequently Asked Questions

Does NEPH pay dividends?

Nephros Inc (NEPH) does not currently pay a regular dividend.

What is NEPH's P/E ratio?

Nephros Inc has a price-to-earnings (P/E) ratio of 52.29.

What is NEPH's market cap?

Nephros Inc (NEPH) has a market capitalization of $39.73M with a current stock price of $3.80.